Filing Details

Accession Number:
0001062993-24-005492
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 16:15:16
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 16:15:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
10456 Baxter International Inc BAX Surgical & Medical Instruments & Apparatus (3841) 360781620
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1362109 K Jeanne Mason One Baxter Parkway
Deerfield IL 60015
Evp, Chief Hr Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $1 Par Value Acquisiton 2024-03-01 64,488 $37.17 206,778 No 4 M Direct
Common Stock, $1 Par Value Disposition 2024-03-01 64,488 $40.61 142,290 No 4 S Direct
Common Stock, $1 Par Value Disposition 2024-03-01 963 $41.01 141,326 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $1 Par Value Stock Option (Right to Buy) Disposition 2024-03-01 64,488 $0.00 64,488 $37.17
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-03-04 No 4 M Direct
Footnotes
  1. Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Ms. Mason on September 6, 2023 with respect to certain vested stock options previously granted by Baxter International Inc. to Ms. Mason which were scheduled to expire on March 4, 2024.
  2. Price reflects weighted average sales price. Range of prices for transactions are $40.28 through $40.93. Full information regarding the number of shares sold at each separate price will be provided by Baxter International Inc. upon request.
  3. Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 1, 2024 from the settlement of vested restricted stock units granted on March 1, 2023.
  4. The options became exercisable in three equal annual installments beginning on March 4, 2015, the first anniversary of the grant date.